Cargando…
Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel
Peritoneal mucinous carcinomatosis is an aggressive subtype of pseudomyxoma peritonei, which often leads to inoperable bowel obstruction and, ultimately, death. Due to the poor prognosis, treatment is often symptomatic and aimed at alleviating the symptoms – pain, nausea, and vomiting – associated w...
Autores principales: | Zafra, Gema Marín, Luque, Pedro Segura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772641/ https://www.ncbi.nlm.nih.gov/pubmed/26933420 http://dx.doi.org/10.1159/000433577 |
Ejemplares similares
-
The Use of Lanreotide Autogel® in the Treatment of Intestinal Obstruction in a Patient with Adenocarcinoma
por: Lybaert, Willem
Publicado: (2014) -
Immunohistochemical and Biochemical Characterization of Mucin in Pseudomyxoma Peritonei: A Case Study
por: Mall, Anwar S., et al.
Publicado: (2011) -
Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential – A Comparison of Two Cases
por: Winer, Ira, et al.
Publicado: (2009) -
Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel(®): A Case Report
por: Lybaert, Willem, et al.
Publicado: (2014) -
A New Etiology for the Abdominal Compartment Syndrome: Pseudomyxoma Peritonei
por: Sabbagh, Charles, et al.
Publicado: (2015)